CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Return to article

Table 1 The Q646C, H647C, and A648C ErbB4 mutants exhibit increased normalized tyrosine phosphorylation

Cell line ErbB4 tyrosine phosphorylation ErbB4 expression Ratio

Wild-type ErbB4 210000 1800000 0.12
ErbB4 Q646C 1900000 3300000 0.58
ErbB4 H647C 2900000 4700000 0.62
ErbB4 A648C 4000000 4500000 0.89





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation